The sirtuin family in health and disease
QJ Wu, TN Zhang, HH Chen, XF Yu, JL Lv… - … and Targeted Therapy, 2022 - nature.com
Sirtuins (SIRTs) are nicotine adenine dinucleotide (+)-dependent histone deacetylases
regulating critical signaling pathways in prokaryotes and eukaryotes, and are involved in …
regulating critical signaling pathways in prokaryotes and eukaryotes, and are involved in …
Fibrosis in chronic kidney disease: pathogenesis and consequences
S Panizo, L Martínez-Arias, C Alonso-Montes… - International journal of …, 2021 - mdpi.com
Fibrosis is a process characterized by an excessive accumulation of the extracellular matrix
as a response to different types of tissue injuries, which leads to organ dysfunction. The …
as a response to different types of tissue injuries, which leads to organ dysfunction. The …
Transforming growth factor-β signaling: from tissue fibrosis to therapeutic opportunities
LL Ren, XJ Li, TT Duan, ZH Li, JZ Yang… - Chemico-biological …, 2023 - Elsevier
Fibrosis refers to the excessive deposition of extracellular matrix components in the
processes of wound repair or tissue regeneration after tissue damage. Fibrosis occurs in …
processes of wound repair or tissue regeneration after tissue damage. Fibrosis occurs in …
New insights into the role and mechanism of partial epithelial-mesenchymal transition in kidney fibrosis
L Sheng, S Zhuang - Frontiers in physiology, 2020 - frontiersin.org
Epithelial-mesenchymal transition (EMT) is described as the process in which injured renal
tubular epithelial cells undergo a phenotype change, acquiring mesenchymal characteristics …
tubular epithelial cells undergo a phenotype change, acquiring mesenchymal characteristics …
TXNIP: A key protein in the cellular stress response pathway and a potential therapeutic target
EH Choi, SJ Park - Experimental & Molecular Medicine, 2023 - nature.com
Abstract Thioredoxin-interacting protein (TXNIP), which is also known as thioredoxin-binding
protein 2 (TBP2), directly interacts with the major antioxidant protein thioredoxin (TRX) and …
protein 2 (TBP2), directly interacts with the major antioxidant protein thioredoxin (TRX) and …
Oxidative stress in the pathogenesis and evolution of chronic kidney disease: untangling Ariadne's thread
A Duni, V Liakopoulos, S Roumeliotis… - International journal of …, 2019 - mdpi.com
Amplification of oxidative stress is present since the early stages of chronic kidney disease
(CKD), holding a key position in the pathogenesis of renal failure. Induction of renal pro …
(CKD), holding a key position in the pathogenesis of renal failure. Induction of renal pro …
Extracellular matrix in kidney fibrosis: more than just a scaffold
Kidney fibrosis is the common histological end-point of progressive, chronic kidney diseases
(CKDs) regardless of the underlying etiology. The hallmark of renal fibrosis, similar to all …
(CKDs) regardless of the underlying etiology. The hallmark of renal fibrosis, similar to all …
Roles and crosstalks of macrophages in diabetic nephropathy
HD Li, YK You, BY Shao, WF Wu, YF Wang… - Frontiers in …, 2022 - frontiersin.org
Diabetic nephropathy (DN) is the most common chronic kidney disease. Accumulation of
glucose and metabolites activates resident macrophages in kidneys. Resident macrophages …
glucose and metabolites activates resident macrophages in kidneys. Resident macrophages …
Macrophage phenotype and fibrosis in diabetic nephropathy
Diabetic nephropathy (DN) is the leading cause of end-stage renal disease globally. The
primary initiating mechanism in DN is hyperglycemia-induced vascular dysfunction, but its …
primary initiating mechanism in DN is hyperglycemia-induced vascular dysfunction, but its …
Oxidative stress markers in chronic kidney disease with emphasis on diabetic nephropathy
N Vodošek Hojs, S Bevc, R Ekart, R Hojs - Antioxidants, 2020 - mdpi.com
Diabetes prevalence is increasing worldwide, especially through the increase of type 2
diabetes. Diabetic nephropathy occurs in up to 40% of diabetic patients and is the leading …
diabetes. Diabetic nephropathy occurs in up to 40% of diabetic patients and is the leading …